Via EDGAR            

  June 11, 2021

U.S. Securities and Exchange Commission

Division of Corporation Finance
Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3720


Jane Park





Second Sight Medical Products, Inc.


Registration Statement on Form S-3


Filed June 8, 2021


File No.  333-256904

Acceleration Request




Requested Date:

June 14, 2021

Requested Time:

4:00 PM Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Second Sight Medical Products, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-256904)(the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”).  The Company hereby authorizes Aaron A. Grunfeld of Law Offices of Aaron A. Grunfeld, counsel for the Company, to make such request on the Company’s behalf.

The Company requests that it be notified of the effectiveness of the Registration Statement by telephone to Aaron A. Grunfeld of Law Offices of Aaron A. Grunfeld & Associates, at (310) 890-0790.  Please also provide a copy of the Commission’s order declaring

Second Sight Medical Products, Inc.

13170 Telfair Ave

Sylmar CA 91342 USA










Securities and Exchange Commission

Re: Second Sight Medical Products, Inc.

June 11, 2021

Page 2






the Registration Statement effective to Aaron A. Grunfeld via email at agrunfeld@grunfeldlaw.com.

Please direct any questions or comments regarding this acceleration request to Aaron A. Grunfeld at (310) 890-0790.





Second Sight Medical Products, Inc.

By: /s/ Scott Dunbar______

     Scott Dunbar

     Acting Chief Executive Officer








Aaron A. Grunfeld, Esq.